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Reversible dementia-the implications of a fall in prevalence
When I took my oral exams in geriatric medicine in the mid 1980s, according to the literature which we then parroted, the percentage of dementias considered to be reversible was at least 20% [1] . However, only a few years later and in the same month, two separate reviews were published pointing out that the prevalence was in fact much lower, that is, just over 11% [2, 3] . By the mid-1990s, [4] and again just over 8 years later in 2003 in an update to the 1988 meta-analysis [5] , the prevalence of reversibility was reported to have decreased to less than even 1%.
What can explain such a rapid fall and what are the clinical implications? Firstly, it is possible that some of the conditions which make up most of the underlying causes of reversibility such as the use of drugs which can cause reversible cognitive decline (benzodiazepines, alcohol, etc.), metabolic causes (such as B 12 deficiency or hypothyroidism) or cognitive decline secondary to depression, have fallen for reasons not entirely clear to us. Secular trends often confound our understanding of disease processes. On the other hand, the prevalence may have stayed the same but these conditions are now being diagnosed earlier and treated more effectively. Finally, there may have been changes in reporting.
To begin with the possibility of a change in the natural history of the reversible dementias, there is little evidence that the prevalence of the underlying diseases has fallen. It is, however, possible that the elderly are indeed better cared for today. For example, Weytingh et al. [4] adduce some indirect evidence that improvements in primary care may have contributed to fewer patients with reversible dementia being referred to the relevant diagnostic frameworks. In support of this proposition, if one compares the data from the 2003 study [5] which updates the 1988 meta-analysis [3] , in the more recent study there is evidence of less selection bias in that far fewer studies now emanate from inpatient units. Many more patients were examined either in outpatient settings or in the community where Alzheimer's disease [AD] (the most common cause of dementia and to date still irreversible) is much more likely to be found [6] . As well, patients who made it into the more recent meta-analysis were both older and more likely to be female than those reported earlier, more clearly reflecting the dementia seen in the community, almost all of which will turn out to be AD [6] .
There is also some evidence that better general education for primary care physicians in the principles of geriatric pharmacology has had a positive effect. For example, while medication as a cause of dementia (not necessarily reversed) was reported in 1.5% of all cases of dementia in 1988, by 2003 this particular aetiology had dropped almost to zero.
Perhaps a more careful use of standardised assessment instruments, consensus diagnosis and sufficient follow-up as a positive spin-off from the increasing number of drug trials for dementia has increased our diagnostic accuracy, both of dementia and of reversibility. Again, support for this hypothesis can be found in an examination of the proportion of cases initially suspected as dementia judged to indeed be suffering from some other condition. In the 1988 meta-analysis this percentage was only 3.7% whereas in the later review [5] it had risen to almost a fifth (18.6%). In the latter case, due to better diagnosis many conditions such as delirium or aphasia would have been excluded from studies, thus lowering the prevalence of reported reversibility.
Additional evidence for better assessment over the last few years can also be found in the work of Walstra et al. [7] who examined 169 patients for reversibility in a dementia clinic. Initially, they found that on clinical impression alone, it did appear that five patients had actually shown cognitive improvement after a potentially reversible aetiology had been treated. However, upon close follow-up (a practice which was not always observed in earlier studies), careful assessment could not confirm any true reversal.
If indeed, dementia reversibility occurs so infrequently, what are the clinical implications? Firstly, for good reasons other than the possibility of uncovering reversibility, old people with cognitive decline require an accurate diagnosis. Perhaps they are not demented. Even if they are, patients and their families will want a clear prognosis. Most patients with dementia will be elderly and as such, often suffer from various co-morbidities. It has become a truism that many of the frail elderly with symptoms of functional decline benefit from comprehensive geriatric assessment [8] . One need not adduce the possibility of dementia reversibility to justify properly examining old people.
However, if the clinician is convinced that reversibility is an extremely rare event, then the search for it should be more focused. If, on the other hand, one believes the prevalence to really be higher, there would be more of a justification for broadening the diagnostic chase, with all of the clinical and resource implications.
This issue has been much debated for example, relating to the question of a universal versus focused recommendation for neuro-imaging. Much ink has been spilt on this question, some of it with passion [9] . To me the choice boils down to what I call the 'Canadian approach' [10] , more focused and clinical, versus the 'American approach' [11] , which argues for a more universal and aggressive testing strategy.
This issue is not a trivial one. An intrusive diagnostic approach, especially if the odds for finding anything are slim, can often do more harm than good, in particular in the frail elderly [12] . With respect to dementia reversibility, it does appear to be a rare event. While older people with cognitive decline need and deserve a careful assessment, the search for reversibility should not be what primarily leads the clinician. Sometimes in geriatric care, it is best to make haste slowly. 
